The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic Approach

Introduction. The development of metabolic syndrome-associated renal dysfunction is exacerbated by a number of factors including dyslipidemia, ectopic deposition of lipids and their toxic metabolites, impairment of lipid metabolism, and insulin resistance. Renal dysfunction is also affected by the p...

Full description

Saved in:
Bibliographic Details
Main Authors: Irena Markova, Denisa Miklankova, Martina Hüttl, Petr Kacer, Jelena Skibova, Jan Kucera, Radislav Sedlacek, Tereza Kacerova, Ludmila Kazdova, Hana Malinska
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2019/8712979
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564422035374080
author Irena Markova
Denisa Miklankova
Martina Hüttl
Petr Kacer
Jelena Skibova
Jan Kucera
Radislav Sedlacek
Tereza Kacerova
Ludmila Kazdova
Hana Malinska
author_facet Irena Markova
Denisa Miklankova
Martina Hüttl
Petr Kacer
Jelena Skibova
Jan Kucera
Radislav Sedlacek
Tereza Kacerova
Ludmila Kazdova
Hana Malinska
author_sort Irena Markova
collection DOAJ
description Introduction. The development of metabolic syndrome-associated renal dysfunction is exacerbated by a number of factors including dyslipidemia, ectopic deposition of lipids and their toxic metabolites, impairment of lipid metabolism, and insulin resistance. Renal dysfunction is also affected by the production of proinflammatory and profibrotic factors secreted from adipose tissue, which can in turn directly impair kidney cells and potentiate insulin resistance. In this study, we investigated the manifestation of renal lipid accumulation and its effect on renal dysfunction in a model of metabolic syndrome—the hereditary hypertriglyceridemic rat (HHTg)—by assessing microalbuminuria and targeted urinary proteomics. Male Wistar control rats and HHTg rats were fed a standard diet and observed over the course of ageing at 3, 12, and 20 months of age. Results. Chronically elevated levels of triglycerides in HHTg rats were associated with increased levels of NEFA during OGTT and over a period of 24 hours (+80%, P<0.01). HHTg animals exhibited qualitative changes in NEFA fatty acid composition, represented by an increased proportion of saturated fatty acids (P<0.05) and a decreased proportion of n-3 PUFA (P<0.01). Ectopic lipid deposition in the kidneys of HHTg rats—triglycerides (+30%) and cholesterol (+10%)—was associated with markedly elevated microalbuminuria as ageing increased, despite the absence of microalbuminuria at the young age of 3 months in these animals. According to targeted proteomic analysis, 3-month-old HHTg rats (in comparison to age-matched controls) exhibited increased urinary secretion of proinflammatory parameters (MCP-1, IL-6, IL-8, P<0.01) and decreased urinary secretion of epidermal growth factor (EGF, P<0.01) before manifestation of microalbuminuria. Elevation in the urinary secretion of inflammatory cytokines can be affected by increased relative expression of MCP-1 in the renal cortex (P<0.05). Conclusions. Our results confirm dyslipidemia and ectopic lipid accumulation to be key contributors in the development of metabolic syndrome-associated renal dysfunction. Assessing urinary secretion of proinflammatory cytokines and epidermal growth factor can help in detecting early development of metabolic syndrome-associated renal dysfunction.
format Article
id doaj-art-ab06606989474a81b1ad75c48b777697
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-ab06606989474a81b1ad75c48b7776972025-02-03T01:11:02ZengWileyJournal of Diabetes Research2314-67452314-67532019-01-01201910.1155/2019/87129798712979The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic ApproachIrena Markova0Denisa Miklankova1Martina Hüttl2Petr Kacer3Jelena Skibova4Jan Kucera5Radislav Sedlacek6Tereza Kacerova7Ludmila Kazdova8Hana Malinska9Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech RepublicCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech RepublicCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech RepublicCzech University of Life Sciences, 16500 Prague, Czech RepublicCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech RepublicCzech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, 25250 Vestec, Czech RepublicCzech Centre for Phenogenomics, Institute of Molecular Genetics of the Czech Academy of Sciences, 25250 Vestec, Czech RepublicDepartment of Chemistry, University College London, London WC1H 0AJ, UKCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech RepublicCentre for Experimental Medicine, Institute for Clinical and Experimental Medicine, 14021 Prague, Czech RepublicIntroduction. The development of metabolic syndrome-associated renal dysfunction is exacerbated by a number of factors including dyslipidemia, ectopic deposition of lipids and their toxic metabolites, impairment of lipid metabolism, and insulin resistance. Renal dysfunction is also affected by the production of proinflammatory and profibrotic factors secreted from adipose tissue, which can in turn directly impair kidney cells and potentiate insulin resistance. In this study, we investigated the manifestation of renal lipid accumulation and its effect on renal dysfunction in a model of metabolic syndrome—the hereditary hypertriglyceridemic rat (HHTg)—by assessing microalbuminuria and targeted urinary proteomics. Male Wistar control rats and HHTg rats were fed a standard diet and observed over the course of ageing at 3, 12, and 20 months of age. Results. Chronically elevated levels of triglycerides in HHTg rats were associated with increased levels of NEFA during OGTT and over a period of 24 hours (+80%, P<0.01). HHTg animals exhibited qualitative changes in NEFA fatty acid composition, represented by an increased proportion of saturated fatty acids (P<0.05) and a decreased proportion of n-3 PUFA (P<0.01). Ectopic lipid deposition in the kidneys of HHTg rats—triglycerides (+30%) and cholesterol (+10%)—was associated with markedly elevated microalbuminuria as ageing increased, despite the absence of microalbuminuria at the young age of 3 months in these animals. According to targeted proteomic analysis, 3-month-old HHTg rats (in comparison to age-matched controls) exhibited increased urinary secretion of proinflammatory parameters (MCP-1, IL-6, IL-8, P<0.01) and decreased urinary secretion of epidermal growth factor (EGF, P<0.01) before manifestation of microalbuminuria. Elevation in the urinary secretion of inflammatory cytokines can be affected by increased relative expression of MCP-1 in the renal cortex (P<0.05). Conclusions. Our results confirm dyslipidemia and ectopic lipid accumulation to be key contributors in the development of metabolic syndrome-associated renal dysfunction. Assessing urinary secretion of proinflammatory cytokines and epidermal growth factor can help in detecting early development of metabolic syndrome-associated renal dysfunction.http://dx.doi.org/10.1155/2019/8712979
spellingShingle Irena Markova
Denisa Miklankova
Martina Hüttl
Petr Kacer
Jelena Skibova
Jan Kucera
Radislav Sedlacek
Tereza Kacerova
Ludmila Kazdova
Hana Malinska
The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic Approach
Journal of Diabetes Research
title The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic Approach
title_full The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic Approach
title_fullStr The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic Approach
title_full_unstemmed The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic Approach
title_short The Effect of Lipotoxicity on Renal Dysfunction in a Nonobese Rat Model of Metabolic Syndrome: A Urinary Proteomic Approach
title_sort effect of lipotoxicity on renal dysfunction in a nonobese rat model of metabolic syndrome a urinary proteomic approach
url http://dx.doi.org/10.1155/2019/8712979
work_keys_str_mv AT irenamarkova theeffectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT denisamiklankova theeffectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT martinahuttl theeffectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT petrkacer theeffectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT jelenaskibova theeffectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT jankucera theeffectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT radislavsedlacek theeffectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT terezakacerova theeffectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT ludmilakazdova theeffectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT hanamalinska theeffectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT irenamarkova effectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT denisamiklankova effectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT martinahuttl effectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT petrkacer effectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT jelenaskibova effectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT jankucera effectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT radislavsedlacek effectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT terezakacerova effectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT ludmilakazdova effectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach
AT hanamalinska effectoflipotoxicityonrenaldysfunctioninanonobeseratmodelofmetabolicsyndromeaurinaryproteomicapproach